The race to test if vaccines hold up against Omicron
Scientists ‘flying at warp speed’ to decode the new Covid-19 variant
Today’s return of mandatory face masks in shops and other measures will “buy us time” as scientists assess the threat level of Omicron, Boris Johnson has said.
The prime minister promised that the latest restrictions, which also include travel restraints, will be reviewed in three weeks when the government hopes to have better information about the effectiveness of vaccines against the new Covid-19 variant.
In the meantime, he is extending the booster vaccine programme as scientists race to understand the effect of Omicron on disease severity and on natural and vaccine immunity.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
‘Evolutionary leap’
Omicron is thought to have evolved from an older strain of the virus known as B.1.1, which has now nearly disappeared, said The Wall Street Journal (WSJ). “It probably spent many months lurking in an immunocompromised person – maybe an HIV/AIDS patient – slowly racking up evolutionary advantages.”
When it was discovered in South Africa after a surge in Covid cases, scientists were “startled”, said Ben Spencer, science editor at The Sunday Times. It had 50 mutations, including 30 on its spike protein, more than double that of the Delta variant. “This was not just a gradual shift, it was an evolutionary leap,” said Spencer.
The fear is that antibodies from the most common vaccines will not recognise the spike protein efficiently and “our hard-won immunity might be side-stepped”, he explained. Ten of the Omicron mutations were also on a section of the spike protein that attaches to human cells, and the theory is that these make it more transmissible. Delta only had two.
While the “genomics do not look good”, this is so far a theoretical risk, said Spencer.
Inside the labs
“Scientists have reacted more quickly to Omicron than to any other variant,” said The New York Times (NYT). They were quick to analyse samples in South Africa, where cases were rising, and alert the world to the new mutation. Since then they have been rushing to test vaccines against it.
“Dozens of teams worldwide – including researchers at Pfizer-BioNTech and Moderna – have joined the chase,” said the NYT.
Penny Moore, a virologist at the National Institute for Communicable Diseases in Johannesburg, South Africa, “is perhaps the furthest along in testing”, said the newspaper. She and her team are “preparing to test blood from fully immunized people against a synthetic version of the Omicron variant”. They will also look at the immunity offered by another component of the immune system called T cells.
Another team at the Africa Health Research Institute is growing a live version of the variant to test.
Dr Stephen Hoge, Moderna’s president, has called Omicron “a Frankenstein mix of all of the greatest hits” and said “it just triggered every one of our alarm bells”. Both Moderna and Pfizer are preparing to reformulate their shots if necessary, potentially within three months.
The NYT said this would be a “miraculous feat”, although added that “the prospect of producing and distributing them raises daunting questions”.
The wait
Moore told Nature her team was “flying at warp speed”, but that results would take around two weeks.
The science journal said researchers are also studying whether Omicron “causes disease that is more severe or milder than that produced by other variants”.
Patients currently infected with Omicron will need “days or weeks” to determine how bad their disease becomes, said the WSJ.
In the UK, Health Secretary Sajid Javid vowed that new measures will not be kept in place for “a day longer than necessary” if Omicron turns out to be milder than expected.
As the wait continues Tom Whipple, science editor at The Times, said overreaction was preferable to underreaction: “Time and time again governments have learnt the hard way that if you wait for perfect data, by the time it arrives it is too late.”
But he added that it was “still perfectly plausible” that when the findings emerge “we might yet discover that the world has indeed overreacted and – happily – merely ended up looking a bit silly”.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
'Republicans want to silence Israel's opponents'
Instant Opinion Opinion, comment and editorials of the day
By Harold Maass, The Week US Published
-
Poland, Germany nab alleged anti-Ukraine spies
Speed Read A man was arrested over a supposed Russian plot to kill Ukrainian President Zelenskyy
By Peter Weber, The Week US Published
-
Today's political cartoons - April 19, 2024
Cartoons Friday's cartoons - priority delivery, USPS on fire, and more
By The Week US Published
-
Covid four years on: have we got over the pandemic?
Today's Big Question Brits suffering from both lockdown nostalgia and collective trauma that refuses to go away
By Chas Newkey-Burden, The Week UK Published
-
The hollow classroom
Opinion Remote school let kids down. It will take much more than extra tutoring for kids to recover.
By Mark Gimein Published
-
Excess screen time is making children only see what is in front of them
Under the radar The future is looking blurry. And very nearsighted.
By Devika Rao, The Week US Published
-
Covid-19: what to know about UK's new Juno and Pirola variants
in depth Rapidly spreading new JN.1 strain is 'yet another reminder that the pandemic is far from over'
By Arion McNicoll, The Week UK Published
-
Long-term respiratory illness is here to stay
The Explainer Covid is not the only disease with a long version
By Devika Rao, The Week US Published
-
Covid inquiry: the most important questions for Boris Johnson
Talking Point Former PM has faced weeks of heavy criticism from former colleagues at the public hearing
By The Week Staff Published
-
China's pneumonia cases: should we be worried?
The Explainer Experts warn against pushing 'pandemic panic button' following outbreak of respiratory illness
By Keumars Afifi-Sabet, The Week UK Published
-
Vallance diaries: Boris Johnson 'bamboozled' by Covid science
Speed Read Then PM struggled to get his head around key terms and stats, chief scientific advisor claims
By The Week UK Published